![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on SWOG S2012: Randomized Phase II/III Trial of 1L Platinum/Etoposide +/- Atezo in Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas
By
ASCO 2022 Conference Coverage
FEATURING
David Zhen
By
ASCO 2022 Conference Coverage
FEATURING
David Zhen
1 view
June 15, 2022
Login to view comments.
Click here to Login
GI